ursodeoxycholic acid
CLINICAL USE
Dissolution of gallstones Primary biliary cirrhosis
DOSE IN NORMAL RENAL FUNCTION
Dissolution of gallstones: 8–12 mg/kg/day in 1–2 divided doses Primary biliary cirrhosis: 10–15 mg/kg/day in 2–4 divided doses
PHARMACOKINETICS
Molecular weight                           : 392.6 %Protein binding                           : 96–98 %Excreted unchanged in urine     : 0 Volume of distribution (L/kg)       : No data half-life – normal/ESRD (hrs)      : No data DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                : Unknown dialysability. Dose as in normal renal function HD                     : Unknown dialysability. Dose as in normal renal function HDF/high flux   : Unknown dialysability. Dose as in normal renal function CAV/VVHD      : Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs Ciclosporin: unpredictably increases the absorption of ciclosporin in some patients ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
– Comments
– OTHER INFORMATION
Completely metabolised in the liver and excreted via the faecal route
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home